Thijs J. Giezen

Safety-Related Regulatory Actions for Biologicals Approved in the United States and the European Union

Thijs J. Giezen, Aukje K. Mantel‐Teeuwisse, Sabine M. J. M. Straus et al. · JAMA · 2008 · 268 citations

Pharmacy, Pharmaceutical Policy, Immunization +16

Interchangeability of Biosimilars: A European Perspective

Pekka Kurki, Leon van Aerts, Elena Wolff‐Holz et al. · BioDrugs · 2017 · 176 citations

Pharmacy, Translational Sciences, Bioequivalence +11

Evaluation of Post-Authorization Safety Studies in the First Cohort of EU Risk Management Plans at Time of Regulatory Approval

Thijs J. Giezen, Aukje K. Mantel‐Teeuwisse, Sabine M. J. M. Straus et al. · Drug Safety · 2009 · 58 citations

Pharmacy, Regulatory Policy, Risk Management +17

Mapping the Safety Profile of Biologicals

Thijs J. Giezen, Aukje K. Mantel‐Teeuwisse, Ronald H.B. Meyboom et al. · Drug Safety · 2010 · 53 citations

Pharmacy, Biological Engineering, Toxicology +12

Safety-Related Regulatory Actions for Orphan Drugs in the US and EU

Harald E. Heemstra, Thijs J. Giezen, Aukje K. Mantel‐Teeuwisse et al. · Drug Safety · 2010 · 39 citations

Pharmacy, Pharmaceutical Policy, Pharmacology +14